STUDY OF THE EFFECT OF OBESITY ON IMMUNE CELLS ACTIVITY AND CARDIOVASCULAR DISEASE RISK IN EL-OUED (ALGERIA) WOMEN
Objective: This study was conducted to find out the effect of obesity on immune cells activity and some biochemical markers in women.
Methods: The experimentation is carried out on 30 voluntary individuals were divided into two groups; 15 women with obesity (Body Mass Index [BMI]>30) were selected, On the other hand, we took 15 witnesses (BMI<30). All the volunteers were subjected to estimate the lipid profile, biochemical, and hematological parameters.
Results: Results obtained show that there was a significant increase of blood glucose (p<0.05), triglyceride (p<0.05) and uric acid (p<0.001) and no significant change of other biochemical markers in obese people’s group when compared to the control subjects. In addition, the hematological results demonstrated that there was a significant decrease (p<0.05) of lymphocytes, hemoglobin, hematocrit, and mean corpuscular volume levels (p<0.01) in women with obesity compared to the controls.
Conclusion: Our study reveals that the obesity may be induce the sever alteration in lipid profile which cause the cardiovascular risk for this population. In addition, the obesity causes a remarkable change in some biochemical markers and blood constituent’s anemia or other metabolic disorder in the body.
2. Omer T. The causes of obesity: An in-depth review. Adv Obes Weight Manag Control 2020;10:90-4.
3. Nuttall FQ. Body mass index. Nutr Today 2015;50:117-28.
4. Derouiche S, Atoussi N, Guediri S. Assessment of hematological parameters, enzymes activities, and oxidative stress markers in salivary and blood of Algerian breast cancer patients receiving chemotherapy. J Biochem Technol 2019;10:50-8.
5. Derouiche S, Taissir C, Abdelmalek D, Achi I. Effect of COVID-19 infection on the immune system and risk of developing diabetes complications: A review. J Pharm Care 2020;8:133-9.
6. Derouiche S, Djouadi A, Belimi N, Louetri K, Hachefa S. Blood glucose, some electrolytes levels and stress oxidative status of female hyperthyroid patients under treatment. J Adv Res Biochem Pharm 2018;3:1-6.
7. Nigatu YT, Reijneveld SA, De Jonge P, Van Rossum E, Bültmann U. The combined effects of obesity, abdominal obesity and major depression/anxiety on health-related quality of life: The LifeLines Cohort Study. PLoS One 2016;11:e0148871.
8. Maiorino MI, Bellastella G, Giugliano D, Esposito K. From inflammation to sexual dysfunctions: A journey through diabetes, obesity, and metabolic syndrome. J Endocrinol Invest 2018;41:1249-58.
9. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
10. Samuel H. The tale of obesity: Challenges and solutions. Best Pract Res Clin Gastroenterol 2005;18:1009-29.
11. Samir D, Kaouther A, Manal D. Polysaccharides and ascorbic acid content and the effect of aqueous extract of portulaca oleracea in high-fat diet-induced obesity, dyslipidemia and liver damage in albino wistar rats. Algerian J Arid Environ 2017;7:16-26.
12. De Lorenzo A, Gratteri S, Gualtieri P, Cammarano A, Bertucci P, Di Renzo L. Why primary obesity is a disease? J Transl Med 2019;17:169.
13. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, Esquivel- Soto J, Morales-González A, Esquivel-Chirino C, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011;12:3117-32.
14. Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: A critical component in human diseases. Int J Mol Sci 2014;16:378-400.
15. Jenna LT, David JH, Gregore IM, Tom GB, Nathan AJ, Michael DL, et al. Effect of high?intensity interval training on visceral and liver fat in cardiac rehabilitation: A randomized controlled trial. Obesity 2020;28:1245-53.
16. King C, Lanaspa MA, Jensen T, Tolan DR, Sánchez-Lozada LG, Johnson RJ. Uric acid as a cause of the metabolic syndrome. Contrib Nephrol 2018;192:88-102.
17. Nielsen SM, Bartels EM, Henriksen M, Wæhrens EE, Gudbergsen H, Bliddal H, et al. Weight loss for overweight and obese individuals with gout: A systematic review of longitudinal studies. Ann Rheum Dis 2017;76:1870-82.
18. Magrone T, Jirillo E. Childhood obesity: Immune response and nutritional approaches. Front Immunol 2015;6:76.
19. Pahwa R, Goyal A, Bansal P, Jialal I. Chronic Inflammation. Treasure Island, FL: StatPearls Publishing; 2020.
20. Aicha Z, El-Houda HN, Samir D. Analysis of osteoporosis risk factors in menopausal women’s of Algeria population. Asian J Res Pharm Sci 2020;10:79-84.
21. Dixon JB, O’Brien PE. Obesity and the white blood cell count: Changes with sustained weight loss. Obes Surg 2006;16:251-7.
22. Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: The linking mechanism and the complications. Arch Med Sci 2017;13:851-63.
23. Derouiche S. Oxidative stress associated with SARS-Cov-2 (COVID-19) increases the severity of the lung disease - A systematic review. J Infect Dis Epidemiol 2020;6:121.
24. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002;87:2084-9.
25. Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, et al. Increased mean platelet volume in patients with slow coronary flow. Platelets 2009;20:23-8.
26. Ferrante AW. The immune cells in adipose tissue. Diabetes Obes Metab 2013;15 Suppl 3(03):34-8.
27. Johnson-Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol 2011;4:177-84.
This work is licensed under a Creative Commons Attribution 4.0 International License.